Insights
Early diagnosis of Alzheimer's disease is crucial. The desire to tackle neurodegenerative diseases by always finding earlier diagnostic solutions and...
Sep 21, 2021
This 2 minute video explains why and how a ratio calculation of the two amyloid proteins, Aβ1-42 and Aβ1-40, offers particularly essential information...
Sep 20, 2021
Biomarkers as effective tools for detecting ovarian cancer recurrence
The American Cancer Society has estimated that in 2021, about 21,410 women in the US will receive a new diagnosis of ovarian cancer (OC), and about 13...
Aug 23, 2021
Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.
...
May 27, 2021
Large-scale and fully automated COVID-19 antigen testing for travelers in German airports
Since November 2020 Fujirebio Europe and CENTOGENE have partnered to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing in...
May 11, 2021
Therapeutic strategies for ovarian cancer and the use of biomarkers for monitoring prognosis
Over the last decades, biomarkers have become an extremely important tool in the care of patients with ovarian cancer. Biomarkers are capable of...
Mar 1, 2021
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand it’s composition. In fact, in the case of...
Nov 3, 2020
During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...
Oct 19, 2020
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
Aug 26, 2020
An overview of ovarian cancer: the development of biomarkers for early detection
It has been estimated that in 2020, about 21,750 women in the US will receive a new ovarian cancer diagnosis and about 13,940 women will die from this...
Jul 29, 2020
Our own Rebecca Millecamps, Marketing Manager at Fujirebio, was interviewed for the podcast series 'Molecules, microbes and multiomics' about the...
Jun 22, 2020